FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

65564011000036101: Sodium Chloride (AstraZeneca) (sodium chloride 45 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use)

Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3006471000168119 Sodium Chloride (AstraZeneca) (sodium chloride 45 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3006481000168116 Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 mL ampoule en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 mL ampoule has manufactured dose form injection true Inferred relationship Some
Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 mL ampoule has Australian BoSS sodium chloride true Inferred relationship Some 1038916654
Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 mL ampoule Is a trade product unit of use true Inferred relationship Some
Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 mL ampoule Is a Sodium Chloride (AstraZeneca) true Inferred relationship Some
Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 mL ampoule Is a sodium chloride 0.9% (45 mg/5 mL) injection, ampoule true Inferred relationship Some
Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 mL ampoule has manufactured dose form injection solution false Inferred relationship Some
Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 mL ampoule has intended active ingredient sodium chloride true Inferred relationship Some 1038916654
Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 mL ampoule has unit of use ampoule true Inferred relationship Some 1038916655
Inbound Relationships Type Active Source Characteristic Refinability Group
Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 10 x 5 mL ampoules has TPUU True Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 mL ampoule Inferred relationship Some 1
Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 10 x 5 mL ampoules has TPUU True Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 mL ampoule Inferred relationship Some 1
Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 50 x 5 mL ampoules has TPUU True Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 mL ampoule Inferred relationship Some 1
Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 x 5 mL ampoules has TPUU True Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 mL ampoule Inferred relationship Some 1
Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 50 x 5 mL ampoules has TPUU True Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 mL ampoule Inferred relationship Some 1
Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 x 5 mL ampoules has TPUU True Sodium Chloride (AstraZeneca) 0.9% (45 mg/5 mL) injection, 5 mL ampoule Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start